The effect of teriparatide treatment on the risk of clinical fragility fractures in postmenopausal women with osteoporosis: Results from the asian and latin america fracture observational study (alafos)

Yang, HuilinAl Ali, NadiaBorges, JoaoBrnabic, AlanCasas, NoemiChen, Chung-HwanElsalmawy, AbdulazizGürbüz, SirelIsh-Shalom, SophiaLim, Seung-JaeMarin, FernandoMoll, ThomasPavo, ImreFlorez, Sandra2024-07-082024-07-082020-11-010884-0431https://hdl.handle.net/11452/43027Bu çalışma, 11-15 Eylül 2020 tarihleri arasında düzenlenen Annual Meeting of the American-Society-for-Bone-and Mineral Research (ASBMR)’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineEndocrinology & metabolismThe effect of teriparatide treatment on the risk of clinical fragility fractures in postmenopausal women with osteoporosis: Results from the asian and latin america fracture observational study (alafos)Meeting Abstract00059311930077625525535Supplement 1, Special Issue